Michael Halstead - Intra Cellular Insider

ITCI -- USA Stock  

USD 20.28  0.17  0.83%

Sr. VP, General Counsel and Secretary
Mr. Michael I. Halstead is Senior Vice President, General Counsel, Secretary of IntraCellular Therapies, Inc. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporationrationrate Development at Warner Chilcott where he directed the companys corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk Wardwell
Age: 43  SVP Since 2014      
646-440-9333  http://www.intracellulartherapies.com
Halstead received his bachelor?s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.

Michael Halstead Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of (17.14) % which means that it has lost $17.14 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (27.39) % meaning that it created substantial loss on money invested by shareholders.

Similar Executives

Found 3 records

SVP Since

Bob BrownDicerna Pharmaceuticals
2012
David NovackDynavax Technologies Corporatio
2013
Robert CoffmanDynavax Technologies Corporatio
2014

Entity Summary

Intra-Cellular Therapies, Inc., a biopharmaceutical company, engages in developing novel drugs for the treatment of neuropsychiatric and neurodegenerative diseases. Intra-Cellular Therapies, Inc. is headquartered in New York, New York. Intra Cellular operates under Biotechnology classification in USA and traded on BATS Exchange. It employs 49 people.Intra Cellular Therapies (ITCI) is traded on BATS Exchange in USA. It is located in NEW YORK U.S.A and employs 49 people. Intra Cellular is listed under Pharmaceutical Products category by Fama And French industry classification.

Intra Cellular Thera Leadership Team

Lawrence Wennogle, President, Ph.D
Christopher Alafi, Director
Michael Rawlins, Director
Robert Nostrand, Director
Richard Lerner, Director
Robert Davis, President, Ph.D
Allen Fienberg, Founder, Ph.D
Michael Halstead, SVP
Sharon Mates, Chairman, Ph.D
Andrew Satlin, President
Juan Sanchez, President
Rory Riggs, Director, MBA
Joel Marcus, Director
Kimberly Vanover, VP, Ph.D
Lawrence Hineline, President, CPA

Stock Performance Indicators

Did you try this?

Run Chance of Distress Now
   

Chance of Distress

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Chance of Distress

Build Optimal Portfolios

Align your risk with return expectations
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
Please also check Risk vs Return Analysis. Please also try Balance Of Power module to check stock momentum by analyzing balance of power indicator and other technical ratios.